C.J. Lintott
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
-
- Lipoproteins and Cardiovascular Health
Papers in
- Surgery 9
- Lipoproteins and Cardiovascular Health 8
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Diet, Metabolism, and Disease 1
- Diabetes Management and Research 1
- Co-authors
- Russell Scott (13 shared papers)Peter M. George (1 shared paper)Jon Bremer (2 shared papers)W. H. F. Sutherland (2 shared papers)Brett Shand (1 shared paper)K. M. Bowen (1 shared paper)Timothy A. Welborn (1 shared paper)Paul Zimmet (1 shared paper)
- Journals
- Diabetes Research and Clinical Practice (2 papers)Human Mutation (1 paper)Current Medical Research and Opinion (1 paper)Breast Cancer Research and Treatment (1 paper)Atherosclerosis (1 paper)
- Partner nations
- New ZealandAustraliaSouth Africa
In The Last Decade
C.J. Lintott
18 papers receiving 238 citations
Peers
Comparison fields: 5 of 56
- Endocrinology, Diabetes and Metabolism 82
- Surgery 130
- Nephrology 14
- Cardiology and Cardiovascular Medicine 38
- Pharmacology 26
Countries citing papers authored by C.J. Lintott
This map shows the geographic impact of C.J. Lintott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J. Lintott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J. Lintott more than expected).
Fields of papers citing papers by C.J. Lintott
This network shows the impact of papers produced by C.J. Lintott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J. Lintott. The network helps show where C.J. Lintott may publish in the future.
Co-authors
The 25 scholars most cited alongside C.J. Lintott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Simvastatin and side effects. | 1991 | 36 |
| 2 | 2002 | 35 | |
| 3 | 1995 | 27 | |
| 4 | 1999 | 26 | |
| 5 | 1991 | 19 | |
| 6 | Dexfenfluramine reduces cardiovascular risk factors. | 1994 | 16 |
| 7 | 1993 | 15 | |
| 8 | 1989 | 14 | |
| 9 | 1985 | 13 | |
| 10 | 1995 | 11 | |
| 11 | 2018 | 9 | |
| 12 | 1992 | 7 | |
| 13 | 1992 | 6 | |
| 14 | Meeting the challenges of interpreting variants of unknown clinical significance in BRCA testing. | 2015 | 6 |
| 15 | 1993 | 3 | |
| 16 | 1989 | 3 | |
| 17 | 2021 | 2 | |
| 18 | Patterns of referral and uptake of BReast CAncer (BRCA) gene testing of eligible women with ovarian cancer in New Zealand. | 2019 | 1 |
| 19 | 2020 | 0 |
About C.J. Lintott
C.J. Lintott is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine, having authored 19 papers that have together received 249 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), BRCA gene mutations in cancer (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Diet, Metabolism, and Disease (1 paper), Pharmaceutical Practices and Patient Outcomes (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Diabetes Management and Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (82 citations), Surgery (130 citations), Nephrology (14 citations), Cardiology and Cardiovascular Medicine (38 citations) and Pharmacology (26 citations). C.J. Lintott has collaborated with scholars based in New Zealand, Australia and South Africa. Frequent co-authors include Russell Scott, Peter M. George, Jon Bremer, W. H. F. Sutherland, Brett Shand, K. M. Bowen, Timothy A. Welborn, Paul Zimmet, Lesley V. Campbell and Edward Janus. Their work appears in journals such as Diabetes Research and Clinical Practice, Human Mutation, Current Medical Research and Opinion, Breast Cancer Research and Treatment and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.